Vireo Growth Inc. (VREOF)
OTCMKTS · Delayed Price · Currency is USD
0.5200
+0.0190 (3.79%)
Jul 29, 2025, 4:00 PM EDT
Vireo Growth Company Description
No description found for Vireo Growth Inc..
Vireo Growth Inc.
| Country | United States |
| Founded | 2004 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 520 |
| CEO | John Mazarakis |
Contact Details
Address: 207 South 9th Street Minneapolis, British Columbia British Columbia United States | |
| Phone | 612 999 1606 |
Stock Details
| Ticker Symbol | VREOF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Amber H. Shimpa | President, Company Secretary and Chief Executive Officer of Vireo Health of Minnesota |
| John Michael Mazarakis | Chief Executive Officer and Co-Executive Chairman |
| Dr. Kyle E. Kingsley M.D. | Founder and Co-Executive Chairman |
| J. Tyson Macdonald | Chief Financial Officer |
| Joseph Duxbury | Chief Accounting Officer |
| Brendan Sweeny | Executive Vice President of Operations |
| Eric Greenbaum J.D. | Chief Scientific Officer |
| Nicole Stanton | Outside General Counsel |
| Aaron Garrido | Vice President and Chief of Staff |
| Brandon Van Asten | Vice President of Finance and Controller |